Targeted lung denervation won’t replace drug therapy but instead has the potential to complement drug therapy for patients with moderate to severe COPD. Dr Dirk-Jan Slebos, from the University Medical Centre Groningen, Netherlands, presented the findings of AIRFLOW 2 – a phase 2 randomised controlled study of targeted lung denervation plus tiotropium versus sham bronchoscopy ...
COPD
Promise in targeting parasympathetic nerve in COPD
By Mardi Chapman
24 Sep 2018